Pharma stocks exhibited remarkable resilience in the morning trade on Wednesday, July 9, despite US President Donald Trump’s threat of a very high tariff of up to 200 per cent.

Several pharma stocks, including Laurus Labs, Lupin, Biocon, Cipla and Divi’s Labs, rose up to 3 per cent in the morning session, pushing their sectoral index, Nifty Pharma, higher by about half a per cent in a weak market.

(This is a developing story. Please check back for fresh updates.)